» Articles » PMID: 16284201

Role of the Bombyx Mori R2 Element N-terminal Domain in the Target-primed Reverse Transcription (TPRT) Reaction

Overview
Specialty Biochemistry
Date 2005 Nov 15
PMID 16284201
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

R2 is a site-specific non-long terminal repeat (non-LTR) retrotransposon encoding a single polypeptide with reverse transcriptase, DNA endonuclease and nucleic acid-binding domains. The current model of R2 retrotransposition involves an ordered series of cleavage and polymerization steps carried out by at least two R2 protein subunits, one bound upstream and one bound downstream of the integration site. The role in the retrotransposition reaction of two conserved DNA-binding motifs, a C2H2 zinc finger (ZF) and a Myb motif, located within the N-terminal domain of the protein are explored in this report. These motifs do not appear to play a role in RT or the ability of the protein to bind the R2 RNA transcript. Methylation and missing nucleoside interference-based DNA footprints using polypeptides to the N-terminal domain suggest the ZF and Myb motifs bind to regions -3 to -1 and +10 to +15 with reference to the insertion site. Mutations in these DNA sites or of the N-terminal protein domain blocked binding and the activity of the downstream subunit. Mutations of the protein domain also affected binding of the upstream subunit but not its function, suggesting the primary path to DNA target recognition by R2 involves both upstream and downstream subunits.

Citing Articles

Conserved and divergent DNA recognition specificities and functions of R2 retrotransposon N-terminal domains.

Lee R, Horton C, Van Treeck B, McIntyre J, Collins K Cell Rep. 2024; 43(5):114239.

PMID: 38753487 PMC: 11204384. DOI: 10.1016/j.celrep.2024.114239.


Distinct and overlapping RNA determinants for binding and target-primed reverse transcription by Bombyx mori R2 retrotransposon protein.

Rodriguez-Vargas A, Collins K Nucleic Acids Res. 2024; 52(11):6571-6585.

PMID: 38499488 PMC: 11194090. DOI: 10.1093/nar/gkae194.


Schlafen-5 inhibits LINE-1 retrotransposition.

Ding J, Wang S, Liu Q, Duan Y, Cheng T, Ye Z iScience. 2023; 26(10):107968.

PMID: 37810251 PMC: 10551903. DOI: 10.1016/j.isci.2023.107968.


Structure of the R2 non-LTR retrotransposon initiating target-primed reverse transcription.

Wilkinson M, Frangieh C, Macrae R, Zhang F Science. 2023; 380(6642):301-308.

PMID: 37023171 PMC: 10499050. DOI: 10.1126/science.adg7883.


A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique.

Kou Y, Wang S, Ma Y, Zhang N, Zhang Z, Liu Q Front Pharmacol. 2022; 13:881938.

PMID: 35685648 PMC: 9171067. DOI: 10.3389/fphar.2022.881938.


References
1.
Esnault C, Maestre J, Heidmann T . Human LINE retrotransposons generate processed pseudogenes. Nat Genet. 2000; 24(4):363-7. DOI: 10.1038/74184. View

2.
Kojima K, Fujiwara H . Long-term inheritance of the 28S rDNA-specific retrotransposon R2. Mol Biol Evol. 2005; 22(11):2157-65. DOI: 10.1093/molbev/msi210. View

3.
Wolfe S, Nekludova L, Pabo C . DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct. 2000; 29:183-212. DOI: 10.1146/annurev.biophys.29.1.183. View

4.
Anzai T, Takahashi H, Fujiwara H . Sequence-specific recognition and cleavage of telomeric repeat (TTAGG)(n) by endonuclease of non-long terminal repeat retrotransposon TRAS1. Mol Cell Biol. 2000; 21(1):100-8. PMC: 88784. DOI: 10.1128/MCB.21.1.100-108.2001. View

5.
Bibillo A, Eickbush T . The reverse transcriptase of the R2 non-LTR retrotransposon: continuous synthesis of cDNA on non-continuous RNA templates. J Mol Biol. 2002; 316(3):459-73. DOI: 10.1006/jmbi.2001.5369. View